Jay D. Amsterdam
#146,834
Most Influential Person Now
Jay D. Amsterdam's AcademicInfluence.com Rankings
Jay D. Amsterdampsychology Degrees
Psychology
#3203
World Rank
#3638
Historical Rank
Clinical Psychology
#287
World Rank
#291
Historical Rank
Download Badge
Psychology Biology
Why Is Jay D. Amsterdam Influential?
(Suggest an Edit or Addition)Jay D. Amsterdam's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antidepressant drug effects and depression severity: a patient-level meta-analysis. (2010) (1696)
- Cognitive therapy vs medications in the treatment of moderate to severe depression. (2005) (954)
- Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. (2005) (703)
- The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. (2013) (551)
- Personality change during depression treatment: a placebo-controlled trial. (2009) (339)
- Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. (1985) (326)
- Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. (2009) (291)
- Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. (1994) (223)
- Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. (1985) (217)
- Complementary and alternative medicine use among cancer survivors: a population-based study (2011) (206)
- Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. (1998) (202)
- Insulin resistance after oral glucose tolerance testing in patients with major depression. (1988) (198)
- Treatment-resistant depression: definition and treatment approaches. (1990) (198)
- Taste and smell perception in depression (1987) (191)
- Antidepressant Drug Effects and Depression Severity (2010) (177)
- Interruption of selective serotonin reuptake inhibitor treatment (2000) (168)
- A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder (2009) (164)
- Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. (1982) (158)
- Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. (1983) (158)
- Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. (2014) (154)
- Changes in weight during a 1-year trial of fluoxetine. (1999) (153)
- Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. (2002) (153)
- Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. (1998) (152)
- Two aspects of the therapeutic alliance: differential relations with depressive symptom change. (2011) (143)
- Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study (1987) (142)
- The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. (1982) (141)
- Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder (2008) (138)
- The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. (1980) (137)
- Borna disease virus. A possible etiologic factor in human affective disorders? (1985) (136)
- A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. (2003) (129)
- Fluoxetine efficacy in menopausal women with and without estrogen replacement. (1999) (127)
- Sudden gains in cognitive therapy of depression and depression relapse/recurrence. (2007) (125)
- Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. (2010) (117)
- Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. (1997) (113)
- 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. (2005) (113)
- What constitutes an adequate antidepressant trial for fluoxetine? (1990) (112)
- BORNA DISEASE VIRUS-SPECIFIC ANTIBODIES IN PATIENTS WITH HIV INFECTION AND WITH MENTAL DISORDERS (1988) (111)
- Treatment-resistant depression : definition and treatment approaches. Discussion (1990) (110)
- Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. (1998) (109)
- Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression (2001) (109)
- Detection of Borna disease virus-reactive antibodies from patients with affective disorders by western immunoblot technique. (1993) (109)
- Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. (2003) (108)
- Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. (1998) (107)
- Treatment algorithms in treatment-resistant depression. (1996) (99)
- Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. (1987) (97)
- A Prospective Trial of Sertraline for Chronic Subjective Dizziness (2004) (94)
- When should a trial of fluoxetine for major depression be declared failed? (2003) (94)
- Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. (1987) (94)
- Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. (1998) (85)
- Venlafaxine monotherapy in women with bipolar II and unipolar major depression. (2000) (84)
- Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. (2016) (84)
- A neuroendocrine test battery in bipolar patients and healthy subjects. (1983) (84)
- Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction. (2005) (83)
- Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. (2007) (83)
- A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data (2009) (83)
- Open trial of buspirone in the treatment of major depressive disorder. (1986) (82)
- Buspirone in major depression: a controlled study. (1991) (81)
- Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. (2012) (80)
- Rhodiola rosea L. as a putative botanical antidepressant. (2016) (79)
- Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. (2008) (78)
- Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. (2015) (77)
- PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. (2004) (77)
- Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. (2007) (75)
- Treatment-Associated Suicidal Ideation and Adverse Effects in an Open, Multicenter Trial of Fluoxetine for Major Depressive Episodes (2006) (75)
- MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective study. (2005) (75)
- A Preliminary Study of Dopamine Transporter Binding in Bipolar and Unipolar Depressed Patients and Healthy Controls (2007) (73)
- The relation of patients' treatment preferences to outcome in a randomized clinical trial. (2007) (72)
- Breast enlargement during chronic antidepressant therapy. (1997) (71)
- The oCRH stimulation test before and after clinical recovery from depression. (1988) (70)
- Positive and negative acute phase proteins in affective subtypes. (1998) (70)
- Multiple hormonal responses to protirelin (TRH) in depressed patients. (1983) (68)
- Neuroendocrine Aspects of Chronic Fatigue Syndrome (2004) (67)
- Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study (2005) (67)
- Selegiline Transdermal System in the Prevention of Relapse of Major Depressive Disorder: A 52-Week, Double-blind, Placebo-Substitution, Parallel-Group Clinical Trial (2006) (66)
- A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. (1998) (64)
- Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study (2008) (63)
- Open trial of gepirone in the treatment of major depressive disorder (1987) (63)
- Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate. (2004) (62)
- Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. (2000) (59)
- Predictors of patient cognitive therapy skills and symptom change in two randomized clinical trials: the role of therapist adherence and the therapeutic alliance. (2012) (58)
- Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients (1987) (58)
- Treatment-Resistant Depression: Progress and Limitations (1998) (57)
- Prediction of steady‐state imipramine and desmethylimipramine plasma concentrations from single‐dose data (1979) (57)
- The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness (1989) (56)
- A placebo‐controlled, double‐blind, clinical trial of paroxetine in depressed outpatients (1989) (56)
- Patterns of melatonin rhythms in depression. (1986) (54)
- Fluoxetine efficacy in treatment resistant depression (1994) (53)
- Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. (1996) (52)
- The effect of post-injury depression on return to pre-injury function: a prospective cohort study (2009) (50)
- Response to dexamethasone in psychotic depression (1983) (50)
- Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. (2007) (49)
- A possible antiviral action of lithium carbonate in herpes simplex virus infections (1990) (49)
- Bone density measurement in major depression (1998) (49)
- High dose tranylcypromine therapy for refractory depression. (1989) (48)
- Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. (2016) (47)
- Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers (1989) (46)
- Autoantibody disturbances in affective disorders: a function of age and gender? (1999) (45)
- Antidepressant monotherapy for bipolar type II major depression. (2003) (45)
- Efficacy and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy of Bipolar II Major Depressive Episode (2010) (45)
- Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. (2009) (44)
- Temporal lobe asymmetry with iofetamine (IMP) SPECT imaging in patients with major depression. (1992) (44)
- Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. (2015) (42)
- A Patient-Level Meta-analysis (2009) (42)
- Adrenocortical responsiveness to the ACTH stimulation test in depressed patients and healthy volunteers. (1986) (42)
- Low brain serotonin transporter binding in major depressive disorder (2012) (40)
- Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers. (1981) (40)
- Effects of psychotropic drugs on human sperm motility. (1981) (40)
- Changes in adverse events reported by patients during 6 months of fluoxetine therapy. (1999) (39)
- Blood pressure changes during short-term fluoxetine treatment. (1999) (39)
- Neuroendocrine regulation in depressed postmenopausal women and healthy subjects (1983) (39)
- The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability. (2008) (39)
- Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression (1992) (38)
- Treatment-resistant mood disorders: Economic and ethical issues (2001) (38)
- Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression (2002) (38)
- Fluoxetine in major depression: a controlled study (1986) (37)
- Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder (2009) (37)
- HMPAO spect brain imaging in treatment-resistant depression (1997) (37)
- Gains in employment status following antidepressant medication or cognitive therapy for depression (2015) (36)
- Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment (2000) (36)
- Clomipramine augmentation in treatment‐resistant depression (1997) (35)
- Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. (2013) (35)
- Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression. (1994) (34)
- Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: Effectiveness and mood conversion rate (2016) (34)
- Immunologic Aspects of Chronic Fatigue Syndrome (2004) (34)
- A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo an Outpatients with Major Depression (1998) (34)
- Rapid Antidepressant Response After Nocturnal TRH Administration in Patients With Bipolar Type I and Bipolar Type II Major Depression (2005) (33)
- A family history study of rapid-cycling bipolar disorder (1993) (33)
- Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy. (2008) (32)
- Greater striatal dopamine transporter density may be associated with major depressive episode. (2012) (32)
- Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers (1982) (32)
- Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (alpha1-24-corticotropin) in depressed patients. (1989) (32)
- Safety and Efficacy of s-Citalopram in Patients with Co-Morbid Major Depression and Diabetes Mellitus (2007) (31)
- Handbook of Drug Therapy in Psychiatry (1984) (30)
- Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine (2010) (29)
- Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder (2013) (29)
- The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance. (2016) (28)
- Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale. (2007) (28)
- Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression (1998) (28)
- Drs. Amsterdam and Mendels Reply (1980) (28)
- Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: A Phase 2 Randomized Clinical Trial. (2019) (28)
- Multiple hormonal responses to insulin-induced hypoglycemia in depressed patients and normal volunteers. (1987) (27)
- Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder (2004) (27)
- Randomized, Double-Blind, Placebo-Controlled Trial of Cimicifuga racemosa (Black Cohosh) in Women With Anxiety Disorder Due to Menopause (2009) (27)
- The ACTH stimulation test before and after clinical recovery from depression (1987) (27)
- Psychiatric Disorders in Patients Presenting to the Emergency Department for Minor Injury (2007) (26)
- The analysis of binary longitudinal data with time‐dependent covariates (2012) (26)
- Suppression of Herpes Simplex Virus Infections with Oral Lithium Carbonate—A Possible Antiviral Activity (1996) (26)
- Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy (2010) (26)
- Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode? (2009) (26)
- Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response. (1984) (26)
- Cerebral HMPAO spect in patients with major depression and healthy volunteers (1996) (26)
- The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. (1992) (26)
- Buspirone in depressed outpatients: a controlled study. (1990) (25)
- Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response. (1985) (25)
- Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. (1986) (25)
- Treatment-resistant depression in the age of serotonin: evolving strategies (2000) (25)
- TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. (1996) (25)
- Dr. Amsterdam and Associates Reply (1982) (24)
- Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression. (2019) (23)
- Dopamine transporter density may be associated with the depressed affect in healthy subjects (2007) (23)
- Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. (2002) (22)
- Treatment of Refractory Depression with Combination Reserpine and Tricyclic Antidepressant Therapy (1987) (22)
- Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome (2009) (22)
- A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A—a putative, new antidepressant (2002) (22)
- The effect of postinjury depression on quality of life following minor injury. (2014) (22)
- Lithium-induced renal disease: a prospective study. (1988) (20)
- Change Over Time in Brain Serotonin Transporter Binding in Major Depression: Effects of Therapy Measured with [123I]‐ADAM SPECT (2013) (20)
- Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications. (2007) (20)
- DISTINGUISHING DEPRESSION SUBTYPES BY THYROTROPIN RESPONSE TO TRH TESTING (1979) (20)
- Rapid conversion from one monoamine oxidase inhibitor to another. (1997) (19)
- Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression (2009) (18)
- A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression. (1986) (18)
- Hormonal and behavioral effects associated with intravenousl-tryptophan administration (2004) (17)
- Changes in Patients’ Beliefs About the Causes of their Depression Following Successful Treatment (2007) (17)
- Nocturnal serum melatonin in major depressive disorder before and after desmethylimipramine treatment. (1985) (17)
- Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial. (2014) (17)
- Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project (2018) (17)
- The ACTH stimulation test in depression. (1985) (16)
- Rates of flu-like infection in patients with affective illness. (1998) (16)
- Step‐wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression (2016) (15)
- Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin (1983) (14)
- A novel arylsulfatase A protein variant and genotype in two patients with major depression. (1996) (14)
- Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder. (2017) (14)
- Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial. (2014) (14)
- Effect of tricyclic antidepressants on the dexamethasone suppression test. (1981) (13)
- Hormonal responses during insulin-induced hypoglycemia in manic-depressed, unipolar depressed, and healthy control subjects. (1991) (13)
- Mood Disorders in Women From Adolescence to Late Life: An Overview (2004) (13)
- Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression. (2019) (13)
- Convergence and divergence in the delivery of cognitive therapy in two randomized clinical trials. (2013) (13)
- Reduced rate of recurrent genital herpes infections with lithium carbonate. (1990) (13)
- Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. (2004) (13)
- Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. (1989) (12)
- Rapid versus non‐rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk (2016) (12)
- Suppression of recurrent genital herpes infections with lithium carbonate: a randomized, placebo-controlled trial (1991) (12)
- A prospective study of lithium-induced nephropathy: preliminary results. (1985) (12)
- Overview of treatment-resistant depression and its management (2001) (11)
- High dose desipramine, plasma drug levels and clinical response. (1979) (11)
- Gonadotropin (LH and FSH) response after submaximal GnRH stimulation in depressed premenopausal women and healthy controls (1995) (11)
- Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder (2008) (11)
- An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder. (2018) (11)
- Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients. (1980) (10)
- EFFECT OF GONADOTROPIN-RELEASING HORMONE ON DEPRESSED MOOD (1979) (10)
- Clinical and Biological Correlates of Treatment-Resistant Depression: An Overview (1994) (10)
- Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness (1990) (9)
- On The Violation Of Bounds For The Correlation In Generalized Estimating Equation Analyses Of Binary Data From Longitudinal Trials (2006) (9)
- Sperm function in affective illness. (1981) (9)
- Effects of Psychotropic Drugs on Human Sperm Motility (1982) (9)
- Monoamine Oxidase Inhibitors Revisited (2001) (9)
- The paroxetine 352 bipolar trial: A study in medical ghostwriting. (2012) (9)
- Improvement in ratings of tension after TRH administration in healthy women (1982) (8)
- The dexamethasone suppression test as a predictor of antidepressant response (2004) (8)
- Complementary and alternative medicine therapies in mood disorders (2011) (8)
- Thyrotropin-releasing hormone's mood-elevating effects in depressed patients, anorectic patients, and normal volunteers. (1981) (8)
- Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study. (1998) (8)
- Loeffler's syndrome: an uncommon adverse reaction to imipramine. (1986) (8)
- Serum antibodies to herpes simplex virus types I and II in depressed patients (1993) (8)
- Drs. Amsterdam and Brunswick Reply (1981) (8)
- Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial. (2004) (8)
- Effectiveness and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy in Patients With Rapid Cycling Bipolar II Depression Versus Patients With Nonrapid Cycling Bipolar II Depression (2013) (8)
- Factors contributing to erythrocyte lithium-sodium countertransport activity in lithium-treated bipolar patients. (1989) (7)
- An overview of investigational antidepressants. (1989) (7)
- Cimetidine-induced alterations in desipramine plasma concentrations (2004) (7)
- HMPAO spect brain imaging in treatment-resistant depression (1994) (7)
- Reliability of commercially available tricyclic antidepressant levels. (1980) (7)
- Novel strategies for treatment-resistant depression. (1996) (7)
- Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d’essais randomisés co (2021) (7)
- Fluoxetine and norfluoxetine plasma levels in major depression (1995) (7)
- The prescriber's guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. (2022) (7)
- FLUOXETINE EFFICACY IN TREATMENT-RESISTANT DEPRESSION (1992) (7)
- Acute metabolic response to cold exposure in unipolar and bipolar II patients. (1981) (7)
- Treatment-resistant tardive dyskinesia: a new therapeutic approach. (1979) (6)
- Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial (2018) (6)
- The effects of desmethylimipramine and lithium on human sperm function (1981) (6)
- Diurnal Variation of Growth Hormone Secretion Following Thyrotropin‐Releasing Hormone Infusion in Normal Men (1984) (6)
- 86. Immune dysfunction in affective subtypes (1996) (6)
- Dexamethasone suppression test as a prognostic tool: two case reports. (1981) (6)
- Site variability in treatment outcome in antidepressant trials (2002) (6)
- Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy. (2019) (6)
- A hormetic approach to understanding antidepressant effectiveness and the development of antidepressant tolerance - A conceptual view. (2020) (6)
- Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy. (2001) (6)
- Bipolar Disorder: For Women a Mixed Picture (2000) (6)
- Industry-corrupted psychiatric trials. (2017) (6)
- Kinetics of erythrocyte lithium-sodium countertransport in patients with affective illness before and during lithium therapy. (1988) (5)
- The relationship between the change in thyrotropin response to trh and therapeutic response to desipramine (DMI) in depressed patients (1989) (5)
- Premenstrual Syndrome: Cyclic Symptoms in Women of Reproductive Age (2002) (5)
- Acute phase proteins in affective illness (1995) (5)
- Psychoneuroendocrine aspects of treatment-resistant mood disorders (2001) (5)
- Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164. (2016) (4)
- P-2-63 changes in acute phase proteins in depressed patients, during treatment with fluoxetine and venlafaxine (1995) (4)
- Double‐blind comparison of doxepin and desipramine in patients with primary affective disorder (1982) (4)
- Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression. (2018) (4)
- Treatment-resistant mood disorders: Medical disorders and treatment-resistant depression (2001) (4)
- Prevention of Relapse and Recurrence of Bipolar Type I Depression: A Study Protocol for a Multi-site Randomized, Double-blind, Placebo-substitution Trial (2014) (4)
- Monoamine Oxidase Inhibitor Therapy in Severe and Resistant Depression (2006) (4)
- Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression (2016) (3)
- Bipolar Disorder in Women (2002) (3)
- Double-blind placebo-controlled study of cilobamine in major depression-lack of therapeutic efficacy (1986) (3)
- Lithium and Manic Depression: A Guide (1983) (3)
- Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression. (2019) (3)
- Response to Eppel Letter (2010) (2)
- Effect of erythromycin on tricyclic antidepressant metabolism. (1991) (2)
- Global mental health (2019) (2)
- Increase in pharmacodynamic tolerance after repeated antidepressant trials in treatment-responsive bipolar I depressed subjects: An exploratory study. (2018) (2)
- High dose tranylcypromine for refractory depression (1989) (2)
- Initial Severity and Depressive Relapse in Cognitive Behavioral Therapy and Antidepressant Medications: An Individual Patient Data Meta-analysis (2022) (2)
- The psychobiology of affective disorders : Pfizer Symposium on Depression, Boca Raton, Florida, February 28-29, 1980 (1980) (2)
- I123‐iofetamine (IMP) spect brain imaging in depressed patients: Normalization of temporal lobe asymmetry during clinical recovery (1995) (2)
- Comparison of treatment outcome using two definitions of rapid cycling in subjects with bipolar II disorder (2017) (2)
- The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct (2019) (2)
- Possible nonlinear pharmacokinetics of desipramine after once daily dosing. (1986) (1)
- Alexithymia and somatic conditions in patients with affective illnesses during lithium prophylaxis. (1988) (1)
- Preliminary communication Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode (2008) (1)
- Abstract 10. Demonstration of antibodies to Borna Virus in patients with affective disorders (1985) (1)
- P02.118. Oral chamomile (Matricaria recutita) extract therapy of Generalized Anxiety Disorder (GAD): trial in progress (2012) (1)
- Subject Index Vol. 59, 2009 (2009) (1)
- Serotonergic Function and Depression (1980) (1)
- Treatment-resistant mood disorders: Immunologic factors in treatment-resistant depression (2001) (1)
- S-72-3 Changes in immunological parameters in refractory depression (1996) (1)
- A 36-year-old Man With a History of Non-response to Multiple Medications (2004) (1)
- Treatment-resistant depression: additional perspectives (1992) (1)
- Anti-viral action of lithium carbonate in preventing recurrent herpes simplex virus infections (1989) (1)
- Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects (2004) (1)
- Effect of Cognitive TherapyWith AntidepressantMedications vs Antidepressants Alone on the Rate of Recovery inMajor Depressive Disorder A Randomized Clinical Trial (2016) (1)
- Pharmacotherapy of Depression: Applications for the Outpatient Practitioner (1990) (1)
- Polysomnography in refractory depression (1989) (1)
- Contents Vol. 54, 2006 (2007) (0)
- Hormone responses to GNRH. (1983) (0)
- Effectiveness and safety of monoamine oxidase inhibitor treatment for bipolar depression versus unipolar depression: An exploratory case cohort study (2022) (0)
- Possible suppression of herpes simplex virus infections with lithium carbonate (1996) (0)
- Treatment-resistant mood disorders: Preface (2001) (0)
- Subject Index Vol. 54, 2006 (2007) (0)
- Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009 (2009) (0)
- P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study (2006) (0)
- Books Received (2002) (0)
- Subject Index Vol. 55, 2007 (2007) (0)
- Contents Vol. 55, 2007 (2007) (0)
- The Suppression of Recurrent Herpes Simplex Virus Infections with Lithium Carbonate (1991) (0)
- Appreciation to Reviewers for Psychosomatics (1992) (0)
- Comprar Treatment-Resistant Mood Disorders | Jay D. Amsterdam | 9780521041812 | Cambridge University Press (2007) (0)
- Authors' reply (2013) (0)
- Metachromatic leukodystrophy: A clue to alcoholism (1995) (0)
- TREATMENT ALGORITHMS IN DEPRESSION TRE ATMENT-RESISTANT (1996) (0)
- Proceedings of the psychiatric research society annual meetingExcessive adrenocortical responsiveness to submaximal doses of cosyntropin (ACTH α1–24) in depressed patients (1988) (0)
- LH and FSH response to submaximal GnRH stimulation in depressed and healthy subjects (1994) (0)
- Does weight change following recovery from depression? Evidence from a randomized, placebo-controlled trial with fluoxetine (1998) (0)
- Structural and functional brain imaging in treatment-resistant depression (2001) (0)
- Short communication Breast enlargement during chronic antidepressant therapy (1997) (0)
- RAPID COMMUNICATION Sperm Function in Affective Illness (2005) (0)
- Dr. Fava and Colleagues Reply (1995) (0)
- Reviewers for The American Journal of Psychiatry. (2015) (0)
- Preliminary communication PET brain imaging with ( 11 C)(+)McN5652 shows increased serotonin transporter availability in major depression (2004) (0)
- Contents Vol. 59, 2009 (2009) (0)
- Mood Disorders in Women (2002) (0)
- Acknowledgment of Reviewers (2003) (0)
- Ariel - Volume 5 Number 4 (2018) (0)
- Hormone responses to GNRH To the editor: (1983) (0)
- Therapeutic Challenge: Antidepressant Monotherapy of Major Depressive Episodes in Bipolar II Disorder (2005) (0)
- 138. Gene variants and treatment response in depression and schizophrenia (1996) (0)
- Pharmacotherapy of Bipolar Disorder (2017) (0)
- Iconographies supplémentaires de l'article : TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION (2011) (0)
- Dr. Amsterdam and Colleagues Reply (1998) (0)
- Mao Expectancy of Side Effects of Treatment Scale (2017) (0)
- FLUOXETINE AND NORFLUOXETINE. AUTHORS' REPLY (1998) (0)
- Severe erythema multiforme associated with zimelidine: a case report (1985) (0)
- PROCEEDINGS OF THE PSYCHIATRIC RESEARCH SOCIETY ANNUAL MEETING EXCESSIVE A D R E N O C O R T I C A L RESPONSIVENESS TO SUBMAX1MAL DOSES OF COSYNTROPIN (ACTH ~1-24) IN DEPRESSED PATIENTS (2002) (0)
- Preliminary communication Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial (2008) (0)
- Huntington's Chorea and dimethylaminoethanol (deanol). (1978) (0)
- Subject Index Vol. 11, 2004 (2004) (0)
- Reduced serotonin transporter binding in patients with major depression compared to healthy controls: A SPECT study (2009) (0)
- Comparison of dopamine transporter binding in major depressive disorder and non-depressed controls (2009) (0)
- Contents Vol. 11, 2004 (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jay D. Amsterdam?
Jay D. Amsterdam is affiliated with the following schools:
